| Literature DB >> 36213296 |
Eero A Haapala1,2, Marja H Leppänen1,3, Maarit Lehti1, Niina Lintu2, Tuomo Tompuri2,4, Anna Viitasalo2, Ursula Schwab5,6, Timo A Lakka2,4,7.
Abstract
Objective: Cardiorespiratory fitness has been inversely associated with cardiovascular risk across the lifespan. Some studies in adults suggest that higher cardiorespiratory fitness is associated with cardioprotective metabolite profile, but the evidence in children is lacking. Therefore, we investigated the cross-sectional association of cardiorespiratory fitness with serum nuclear magnetic resonance derived metabolic biomarkers in children.Entities:
Keywords: aerobic fitness; fitness; lipoproteins; metabolism; metabolomics; obesity; pediatrics
Mesh:
Substances:
Year: 2022 PMID: 36213296 PMCID: PMC9538338 DOI: 10.3389/fendo.2022.954418
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 6.055
Characteristics of participants.
| All children (n=450) | Girls (n=217) | Boys (n=233) | p | |
|---|---|---|---|---|
| Age (years) | 7.6 (0.4) | 7.6 (0.4) | 7.7 (0.4) | 0.362 |
| Stature (cm) | 129 (5.5) | 128 (5.7) | 130 (5.2) |
|
| Body weight (kg) | 26.0 (23.6 to 29.3) | 25.5 (23.1 to 29.0) | 26.6 (23.9 to 29.4) | 0.059 |
| Clinical puberty (%) | 2.5 | 4.3 | 0.8 |
|
| Maturity (years) | -4.1 (-4.4 to -3.6) | -3.6 (0.3) | -4.4 (0.3) |
|
| Body mass index standard deviation score | -0.18 (1.1) | -0.15 (1.1) | -0.20 (1.1) | 0.642 |
| Prevalence of overweight (%) | 13.1 | 15.2 | 11.2 | 0.204 |
| Body fat percentage (%) | 18.7 (13.3 to 24.2) | 20.8 (17.4 to 27.0) | 15.0 (11.4 to 21.5) |
|
| Lean body mass (kg) | 20.6 (2.4) | 19.5 (2.1) | 21.6 (2.2) |
|
| Homeostatic Model Assessment of Insulin Resistance | ||||
| Absolute peak power output (W) | 76.7 (15.3) | 69.9 (12.9) | 82.9 (14.6) |
|
| Relative peak power output (W x kg of LM-1) | 3.7 (0.5) | 3.6 (0.5) | 3.8 (0.5) |
|
| Physical activity energy expenditure (kcal x kg-1 x d-1) | 98.4 (32.4) | 90.5 (28.1) | 106 (34.3) |
|
| Moderate to vigorous physical activity (min-1 x d-1) | 115 (61.3) | 97.5 (53.2) | 132 (63.8) |
|
| Finnish Children Healthy Eating Index | 22.8 (7.0) | 23.4 (6.5) | 22.3 (7.2) | 0.094 |
The data are mean (standard deviation) or median (interquartile range). P-values are for the difference between girls and boys from the Students t -test, Mann-Whitney U -test, or χ2 test. Statistically significant differences are bolded. LM, lean mass. Maturity was assessed as the difference between the current age from the age at predicted peak height velocity and was computed using a sex-specific formula described by Moore and coworkers (37).
Associations of cardiorespiratory fitness with NMR-derived metabolic biomarkers.
| Model 1 | Model 2 | BF% x CRF interaction | |||
|---|---|---|---|---|---|
| β (95% CI) | p | β (95% CI) | p | p | |
|
| |||||
|
| |||||
| VLDL cholesterol (mmol/l) | -0.022 (-0.118 to 0.075) | 0.662 | 0.005 (-0.091 to 0.101) | 0.922 | 0.136 |
| LDL cholesterol (mmol/l) | -0.047 (-0.153 to 0.058) | 0.379 | 0.027 (-0.070 to 0.124) | 0.580 |
|
| HDL cholesterol (mmol/l) |
|
|
|
| 0.276 |
| Total triglycerides (mmol/l) | 0.024 (-0.073 to 0.122) | 0.630 | 0.047 (-0.051 to 0.144) | 0.349 | 0.868 |
| Average VLDL diameter (nm) | 0.001 (-0.096 to 0.090) | 0.952 | 0.032 (-0.064 to 0.129) | 0.510 | 0.856 |
| Average LDL diameter (nm) | 0.063 (-0.035 to 0.161) | 0.204 | 0.062 (-0.037 to 0.161) | 0.222 |
|
| Average HDL diameter (nm) |
|
| 0.051 (-0.034 to 0.155) | 0.208 | 0.768 |
| Concentration of medium VLDL particles (mmol/l) | -0.005 (-0.103 to 0.092) | 0.913 | 0.024 (-0.073 to 0.120) | 0.631 | 0.139 |
| Concentration of small VLDL particles (mmol/l) | -0.009 (-0.107 to 0.088) | 0.853 | 0.017 (-0.080 to 0.114) | 0.731 | 0.508 |
| Concentration of extra-small VLDL particles (mmol/l) | 0.002 (-0.095 to 0.099) | 0.968 | 0.012 (-0.085 to 0.110) | 0.802 | 0.202 |
| Concentration of extra-large HDL particles (mmol/l) |
|
| 0.068 (-0.027 to 0.163) | 0.161 | 0.940 |
| Concentration of large HDL particles (mmol/l) |
|
| 0.089 (-0.007 to 0.184) | 0.069 | 0.730 |
| Concentration of medium HDL particles (mmol/l) |
|
|
|
| 0.224 |
| Concentration of small HDL particles (mmol/l) | 0.073 (-0.025 to 0.170) | 0.143 | 0.095 (-0.002 to 0.192) | 0.056 |
|
|
| |||||
| Apolipoprotein B (g/l) | 0.003 (-0.094 to 0.101) | 0.946 | 0.024 (-0.073 to 0.121) | 0.630 | 0.029 |
| Apolipoprotein A1 (g/l) |
|
|
|
| 0.231 |
| Apolipoprotein B to Apolipoprotein A1 ratio | -0.084 (-0.180 to 0.012) | 0.086 | -0.051 (-0.145 to 0.043) | 0.287 | 0.180 |
|
| |||||
| Alanine (mmol/l) | 0.004 (-0.054 to 0.142) | 0.377 | 0.061 (-0.038 to 0.159) | 0.226 | 0.697 |
| Glutamine (mmol/l) |
|
|
|
| 0.387 |
| Glycine (mmol/l) | 0.068 (-0.030 to 0.165) | 0.172 | 0.054 (-0.044 to 0.152) | 0.278 | 0.919 |
| Histidine (mmol/l) | 0.079 (-0.118 to 0.177) | 0.110 | 0.085 (-0.013 to 0.183) | 0.090 | 0.578 |
| Phenylalanine (mmol/l) |
|
|
|
| 0.480 |
| Tyrosine (mmol/l) | 0.031 (-0.067 to 0.129) | 0.537 | 0.060 (-0.036 to 0.157) | 0.220 | 0.283 |
| Isoleucine (mmol/l) | 0.006 (-0.092 to 0.104) | 0.904 | 0.019 (-0.079 to 0.118) | 0.669 | 0.336 |
| Leucine (mmol/l) | 0.049 (-0.049 to 0.147) | 0.325 | 0.071 (-0.027 to 0.169) | 0.156 | 0.547 |
| Valine (mmol/l) | 0.042 (-0.056 to 0.140) | 0.400 | 0.075 (-0.021 to 0.171) | 0.126 | 0.630 |
| Total branched-chain amino acids (mmol/l) | 0.040 (-0.058 to 0.138) | 0.426 | 0.067 (-0.030 to 0.164) | 0.173 | 0.524 |
The data are standardised regression coeffiecients (β) and their 95% confidence intervals (95% CI) adjusted for age and sex (Model 1) and additionally for body fat percentage (model 2). P-values for statistically significant associations and interactions are bolded. BF%, body fat percentage; CRF, cardiorespiratory fitness; HDL, high density lipoprotein; LDL, low density lipoprotein; VLDL, very-low-density lipoprotein.